NJACS - Organic Chemistry Group

NJ-ACS Organic Topical Group

Meetings: [ current | registration | upcoming | past ]

Next Meeting

May Meeting and Symposium

Pharmaceutical Success Stories

Thursday May 22, 2008

Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873

[ Directions | Registration (below) ]

Registration fee: $95.00 (Symposium and Lunch)

Registration	8:30 a.m.
Symposium	9:00 a.m. – 4:30 p.m.
Lunch	12:30 p.m.

Please register according to the instruction below

Invited Speakers

I.
“Process Chemistry at GlaxoSmithKline, The Development of a Manufacturing Route to a Cathepsin K Inhibitor”

William Clark & Robert W. Marquis (GlaxoSmithKline)

II.
“Discovery and Development of SGLT-2 Inhibitors”

Prashant Desphande & Wei Meng (Bristol Myers Squibb)

III.
“Natural Products in Drug Discovery: The Development of Cancidas®”

James Balkovec (Merck Research Laboratories)

IV.
“From R1479 to R1626: Discovery and Advancement of 4’-Substituted Nucleosides for the Treatment of Hepatitis C”

David Smith (Roche)

V.
“The Discovery of Varenicline, a Nicotinic Receptor Partial Agonist for Smoking Cessation”

Jotham Coe (Pfizer)

Registration for the May 22 Symposium

Please use the gray form below to register.

In addition, there is a $95 registration fee for the Symposium and Lunch which should be paid by sending a check to

Dr. Dong Xiao
K-15-1800
Schering Plough Corp.
2015 Galloping Hill Road
Kenilworth NJ 07033

Note: Seating is limited. Please register by May 15. Registration will be on a first come first served basis and will not be complete until your check has been received. Checks should be sent by U.S. Mail.

Checks should be payable to "North Jersey Section ACS".

Registration contact:

Organizing committee:

Lawrence Williams, Chair (Rutgers)
Dong Xiao
Joe Kozlowski (Schering)
Amjad Ali (Merck)
Albert Delmonte (BMS)
Binh Vu (Roche)
Eric Metz (Roche)

Organic Chemistry Topical Group

Registration for May 22 Meeting

Name

		(required)
Dr/etc	First	Last

Company or Institution

Street

City, State Zip

Phone

(required)

E-mail

(required)

Name for Badge (if different from Name above)

Short Message

STOP: Please review the data above for accuracy, before Submitting

Upcoming Meetings

May 22, 2007, Meeting and Symposium -- see above

Past Meetings

Drugs from Academia: Marketed Drugs from Academic Labs

Friday, October 26, 2007

Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873

[ Directions | Registration (below) ]

Registration fee: $95.00 (Symposium and Lunch)

Registration	8:30 a.m.
Symposium	9:00 a.m. – 4:30 p.m.
Lunch	12:30 p.m.

Please register according to the instruction below

Invited Speakers

I.
“Discovery of Alimta, a Broadly Effective New Antitumor Agent”

Edward C. Taylor (Princeton University)

II.
“SAHA (Vorinostat): The First Anticancer HDAC Inhibitor Approved for Human Use”

Ronald Breslow (Columbia University)

III.
“Didanosine (ddI): A Member of the Versatile 2',3'-Dideoxy Family of Biomedicinal Nucleoside Analogues”

Morris J. Robins (Brigham Young University)

IV.
“Basic Science to the Market. The Discovery of Lyrica®”

Richard B. Silverman (Northwestern University)

V.
“The Discovery of 3TC and FTC”

Dennis C. Liotta (Emory Uinversity)

May 24 2007 Meeting and Symposium
[ Group Photo ]

New Methods and Strategies for Heterocyclic Synthesis

Thursday, May 24, 2007

Invited Speakers

I.
"Strategies for the Synthesis of Heterocyclic Natural Products"

Stephen F. Martin (University of Texas, Austin)

II.
"Chemoenzymatic Synthesis of Alkaloids: A Multi-Generational Approach"

Tomas Hudlicky (Brock University, St. Catharines, Ontario, Canada)

III.
"A Conducted Tour of Recent Heteroaromatic Directed ortho Metalation"

Victor Snieckus (Queen's University, Kingston, Ontario, Canada)

IV.
"Synthesis of Heterocycles via Transition Metal-Mediated Catalysis"

Chulbom Lee (Princeton University)

V.
"Cascade Reaction in Complex Alkaloid Synthesis"

Mohammad Movassaghi (MIT)

Speakers and Section Officers at the May Symposium

From left to right: Dr. Binh Vu, Prof. Victor Snieckus, Prof. Lawrence Williams Prof. Steve Martin, Prof. Chulbom Lee, Dr. Albert DelMonte, Prof. Mo Movassaghi, Dr. Amjad Ali, Dr. Gabor Butora, Dr. Dong Xiao, Prof. Tomas Hudlicky.

Friday, November 17, 2006

Discovery, Selection, and Development of Drug Candidates:
A Senior Leadership Perspective

[ photos ]

Poster - Click to enlarge

Speakers:

Keynote Address:
Dr. P. Roy Vagelos (Retired Chairman and CEO, Merck & Co., Inc.)
“The Changing Pharmaceutical Industry”

Dr. Carl Decicco (Bristol-Myers Squibb)
“Innovation in Drug Discovery”

Dr. Paul Feldman (GlaxoSmithKline)
“PPAR Pan Agonists-The Next Generation PPAR Ligands”

Dr. Malcolm MacCoss (Merck)
“EMEND(c) (Aprepitant) a potent, orally active Substance P Antagonist for the treatment of Chemotherapy Induced Nausea and Vomiting (CINV), from the medicinal chemistry bench to the clinic”

Dr. Bruce Roth (Pfizer)
“The Discovery and Development of Lipitor”

Registration Form (pdf)

Location
Somerset Marriott
110 Davidson Avenue
Somerset, New Jersey 08873
(Directions)

This event involved 4 Vice Presidents in charge of research at 4 of the largest Pharma compan ies in the US. The evening ended with a keynote talk by Dr. P. Roy Vagelos (retired Chariman and CEO, Merck).

(Click pictures to enlarge)

Dr. P. Roy Vagelos provides Keynote Address

Drs. Paul Feldman, Malcolm MacCoss, Bruce Roth, Carl Decicco, and 2006 OTG Committee